Accessibility settings

This paper is in the following e-collection/theme issue:

RCTs - Protocols/Proposals (non-eHealth) (971) Depression and Mood Disorders; Suicide Prevention (2518) Bipolar Disorders (131)

Published on in Vol 12 (2023)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/41013, first published .
Doctor interacting with holographic brain model on digital tablet

Neural Correlates of the DEEPP (Anti-suicidal Response to Ketamine in Treatment-Resistant Bipolar Depression) Study: Protocol for a Pilot, Open-Label Clinical Trial

Neural Correlates of the DEEPP (Anti-suicidal Response to Ketamine in Treatment-Resistant Bipolar Depression) Study: Protocol for a Pilot, Open-Label Clinical Trial

Authors of this article:

Yuliya Knyahnytska1 Author Orcid Image ;   Reza Zomorrodi1 Author Orcid Image ;   Tyler Kaster1 Author Orcid Image ;   Daphne Voineskos1 Author Orcid Image ;   Alisson Trevizol1 Author Orcid Image ;   Daniel Blumberger1 Author Orcid Image
Article Authors Cited by (2) Tweetations (2) Metrics

Journals

  1. Dev D, Le G, Kwan A, Wong S, Arulmozhi A, Ceban F, Teopiz K, Meshkat S, Rosenblat J, Guillen-Burgos H, Rhee T, Ho R, Cao B, d'Andrea G, Sundberg I, McIntyre R. Comparing suicide completion rates in bipolar I versus bipolar II disorder: A systematic review and meta-analysis. Journal of Affective Disorders 2024 View
  2. Malewska-Kasprzak M, Rybakowski F, Dmitrzak-Weglarz M. Multimodal predictors of response to intravenous ketamine in treatment-resistant depression: toward personalized treatment in major depressive and bipolar disorders. CNS Spectrums 2026;31(1) View